Dilek Ertoy Baydar
Papers
4
Total Citations
27
H-Index
3
About
Dilek Ertoy Baydar is a leading urologic oncologist whose research focuses on refining risk stratification and surgical precision in prostate cancer management. Her work centers on integrating advanced imaging modalities—particularly PSMA PET/CT and multiparametric MRI—with intraoperative techniques to improve treatment outcomes. A key contribution is her investigation of PSMA PET/CT’s ability to predict pathological upgrading or downgrading after radical prostatectomy, helping to bridge the gap between biopsy findings and final pathology. Her 2023 study on PSMA PET/CT for predicting upgrading in ISUP grade group 1 patients (9 citations) and her 2024 work on downgrading in Gleason score 8 disease (2 citations) highlight this focus. She has also advanced surgical practice through studies on fluorescence-guided extended pelvic lymphadenectomy during robotic prostatectomy (6 citations) and intraoperative frozen section analysis using the Neurosafe technique (10 citations), aiming to optimize nerve-sparing and oncologic control. With over 27 citations across her most influential papers, Baydar’s work is shaping the era of personalized, image-guided prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4